Bioarchitech
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$57.6K
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of oncolytic viruses designed to treat cancer. The company's oncolytic viruses are developed with improved therapeutic amplification at the tumor site and have the ability to survive in the body's circulation to target tumor metastases, which are the main cause of morbidity and mortality, enabling patients to begin treatment more quickly, resulting in a higher likelihood of more successful tumor treatment.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
- BioEscalator, Innovation Building
- University of Oxford, Roosevelt Drive
- Oxford OX3 7FZ
- England, United Kingdom
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Bioarchitech’s full profile, request a free trial.
Bioarchitech Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 03-Apr-2019 | $57.6K | 00000 | 00.000 | Completed | Startup |
| 4. Early Stage VC | 20-Oct-2017 | 00000 | 00000 | 00.000 | Completed | Startup |
| 3. Grant | 01-Dec-2016 | 00000 | 00000 | Completed | Startup | |
| 2. Early Stage VC | 17-Mar-2016 | $70.9K | $226K | 00000 | Completed | Startup |
| 1. Early Stage VC | 13-Aug-2015 | $155K | $155K | 00000 | Completed | Startup |
Bioarchitech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 00,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Ordinary | 00,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Ordinary | 50,000 | $0.001315 | $1.32 | $1.32 | 1x | $1.32 | 5.29% | |
| Ordinary | 165,750 | $0.001315 | $0.79 | $0.79 | 1x | $0.79 | 17.53% |
Bioarchitech Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Innovate UK | Government | 000 0000 | 000000 0 | |||
| Oxford Technology Management | Venture Capital | Minority | 000 0000 | 000000 0 |
Bioarchitech Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Geoffrey Hale Ph.D | Board Member & Managing Director | ||
| Kevin Maskell | Co-Founder & Research Director | ||
| Hannah Chen | Co-Founder |
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »Bioarchitech Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Geoffrey Hale Ph.D | Bioarchitech | Board Member & Managing Director | 000 0000 |
1 Former Board Member
You’re viewing 1 of 2 board members. Get the full list »